Schedule 13G ownership disclosure
Aegerion Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 00767E102
Event date: 2014-10-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,532,824
- Percent of class
- 8.5800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001085146-14-002134
- Form type
- SC 13G
- Filer
- Aegerion Pharmaceuticals, Inc.
- CIK
- CIK 1338042
- Filed
- Nov 10, 2014
- Reporting period
- Oct 31, 2014
- Description
- Schedule 13G beneficial ownership